首页> 外文期刊>Gynecologic and obstetric investigation >Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy
【24h】

Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy

机译:门诊前尿道术前的术前治疗宫腔镜宫颈切除术

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Nowadays, the resection of submucosal myomas is usually performed by hysteroscopy. No previous study has investigated the use of preoperative hormonal therapy before outpatient hysteroscopic myomectomy. Objective: To compare the usefulness of 3-month preoperative treatment with ulipristal acetate (UPA) before outpatient hysteroscopic myomectomy in patients with FIGO (International Federation of Gynecology and Obstetrics) type 0–1 myomas. Study Design: This prospective patient preference?study included women requiring hysteroscopic resection of single FIGO type 0–1 myoma with the largest diameter <2 cm. Patients underwent either preoperative treatment with UPA (5 mg/day) for 3 months or direct surgery. Outpatient myomectomy was performed using the bipolar electrosurgical Versapoint system (Ethicon Gynecare, USA). The primary objective of the study was to compare the rate of complete resections in the 2 study groups. The secondary objective of the study was to compare the operative time and the volume of fluid infused/absorbed. The tertiary objective of the study was to assess the surgical appearance of the myomas in patients treated with UPA. Results: The study included 38 women treated with UPA and 45 women who underwent direct surgery. UPA treatment significantly decreased the volume of uterine myomas ( p < 0.001). The percentage of complete resection was higher in patients treated with UPA (89.5%) than in those who underwent direct surgery (68.9%; p = 0.046). Preoperative UPA treatment decreased the operative time ( p < 0.001) and the volume of fluid infused ( p = 0.016), but it did not significantly affect the volume of fluid absorbed ( p = 0.874). The texture of the myoma was not significantly affected by UPA treatment ( p = 0.142). Conclusions: Three-month UPA treatment improves the chance of single-step complete outpatient hysteroscopic resection of single FIGO type 0–1 myoma. Future randomized studies with a larger sample size should confirm these preliminary findings.
机译:介绍:如今,粘膜肌瘤的切除通常由宫颈检查进行。没有先前的研究已经调查了在门诊前宫腔镜切除术前使用术前荷尔蒙治疗。目的:比较3个月术前治疗与尿醋酸术(UPA)在门诊(国际妇科和产科国际联合会)患者患者宫腔镜切除术前对尿醋酸盐(UPA)的有用性。研究设计:这种预期患者偏好?研究包括需要宫腔镜切除的女性宫颈切除0-1型肌瘤,具有最大直径<2cm。患者经过术前治疗,upa(5 mg /天)3个月或直接手术。使用双极电外科通用符号(Ethicon Gynecare,USA)进行门诊关键心肌切除术。该研究的主要目标是比较2个研究组的完全切除率。该研究的次要目的是将操作时间和流体体积进行比较/吸收。该研究的三级目标是评估用UPA治疗的患者的Myoma的手术外观。结果:该研究包括38名妇女治疗UPA和45名接受直接手术的女性。 UPA治疗显着降低了子宫肌瘤的体积(P <0.001)。用UPA治疗的患者(89.5%)患者的完全切除百分比高于直接手术的患者(68.9%; P = 0.046)。术前UPA处理降低了操作时间(P <0.001),流体输注的流体体积(P = 0.016),但它没有显着影响吸收的流体体积(P = 0.874)。肌瘤的质地不会受到UPA治疗的显着影响(p = 0.142)。结论:三个月的UPA治疗改善了单步完全门诊宫腔镜切除的机会0-1型肌瘤。未来样本大小的随机研究应确认这些初步调查结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号